PRN: Neurostimulation: SCS, DBS, SNS, VNS GES - Global Strategic Business Report 2015

08/gen/2016 13.10.21 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Neurostimulation: SCS, DBS, SNS, VNS GES - Global Strategic Business Report 2015

 
[08-January-2016]
 


DUBLIN, January 8, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/6kcx5m/neurostimulation) has announced the addition of the "Neurostimulation - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

This report analyzes the worldwide markets for Neurostimulation in US$ by the following Product Segments: Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES).

The United States is analyzed both in terms of value (US$) and volume (units) sales.

The report profiles 30 companies including many key and niche players such as

  • Aleva Neurotherapeutics SA (Switzerland)
  • BioControl Medical (Israel)
  • Bioness Inc. (USA)
  • Boston Scientific Corp. (USA)
  • EnteroMedics Inc. (USA)
  • LivaNova PLC (UK)
  • Medtronic, Inc. (USA)
  • NeuroPace, Inc. (USA)
  • NeuroSigma, Inc. (USA)
  • Nevro Corp. (USA)
  • SPR Therapeutics, LLC (US)
  • St. Jude Medical, Inc. (USA)
  • Synapse Biomedical, Inc. (USA)

Key Topics Covered:

1. MARKET OVERVIEW

2. COMPETITIVE SCENARIO

3. GROWTH DRIVERS, TRENDS, & ISSUES

4. MACRO GROWTH DRIVERS FOR NEUROSTIMULATION INDUSTRY

5. TECHNOLOGICAL ADVANCEMENTS IN NEUROSTIMULATION MARKET

6. SELECT TARGETED INDICATIONS

7. PRODUCT OVERVIEW

8. NEUROSTIMULATION DEVICE APPROVALS

9. PRODUCT INNOVATIONS/INTRODUCTIONS

10. RECENT INDUSTRY ACTIVITY

11. FOCUS ON SELECT PLAYERS

12. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 30 (including Divisions/Subsidiaries - 31)

  • The United States (23)
  • Europe (7)
  • - Germany (2)
  • - The United Kingdom (2)
  • - Rest of Europe (3)
  • Middle East (1)

For more information visit http://www.researchandmarkets.com/research/6kcx5m/neurostimulation

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl